Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm

NCT00776724 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Chemotherapy

Interventions

DRUG: Taxotere , Epirubicin
DRUG: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP

Sponsor

National Taiwan University Hospital